Sinovac Biotech gets approval for CoronaVac phase 3 trial in Brazil
CoronaVac phase 3 trial : Sinovac Biotech, a Chinese biopharma company has secured approval in Brazil to begin a phase 3 clinical trial for CoronaVac, its inactivated COVID-19 vaccine candidate. Brazil is currently the second most infected country after the US with the novel coronavirus. The Chinese pharma company has been granted the approval by […]